Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Bioactive Compounds

Items 6141-6150 of 13615

Page
per page
  1. Citalopram hydrobromide
    B6736 Citalopram hydrobromide
    Summary: 5-HT uptake inhibitor
  2. NPEC-caged-(S)-3,4-DCPG
    B7368 NPEC-caged-(S)-3,4-DCPG
    Summary: mGlu8a agonist
      <43.23 mg/mL
  3. SD-36
    BA2753 SD-36
    Summary: SD-36 is an effective degradant (=~50nM) with high selectivity compared to other members.
  4. MTSEA
    C4755 MTSEA
    Summary: A thiol-reactive reagent that can selectively modify cysteine residues.
      ≤30 mg/mL
  5. N-Lauroyl-L-alanine
    BA9430 N-Lauroyl-L-alanine
    Summary: An alanine derivative.
  6. Zymosan A
    A9934 Zymosan A
    Summary: A polysaccharide compound extracted from the cell wall of yeast
      insoluble in DMSO; insoluble in EtOH; insoluble in H2O
  7. Raddeanin A
    N2846 Raddeanin A
    Summary: A triterpenoid saponin derived from plants, which has anticancer activity
      ≥55.8 mg/mL
  8. XY028-133
    BA3796 XY028-133
    Summary: A degrading agent.
  9. DNA31
    BA4061 DNA31
    Summary: An effective inhibitor.
  10. O-Phthalimide-C3-acid
    C8188 O-Phthalimide-C3-acid
    Summary: 4-(N-Phthalimidoyl)butanoicacid (Compound FB) is a hapten. The terminal end of its spacer arm contains a carboxyl group, making it suitable for reacting with free amino groups of proteins.
      ≥35.7 mg/mL

Items 6141-6150 of 13615

Page
per page